Highly selective sodium glucose cotransporter type 2 inhibitor empagliflozin neuroprotective potential in chronic brain dyscirculation

• Egile Nagusiak: Оksana S. Fuks (Egilea), Anna V. Simanenkova (Egilea), Natalya V. Timkina (Egilea), Polina A. Tikhomirova (Egilea), Aleksandr Z. Gagiev (Egilea), Tatiana L. Karonova (Egilea)
• Formatua: Liburua
• Argitaratua: ZAO "Consilium Medicum", 2023-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background. Chronic brain dyscirculation occurs in type 2 diabetes mellitus (DM2) with a high frequency and leads to patients disability. The early diagnosis of this disorder is difficult. Sodium-glucose cotransporter type 2 inhibitors are among the priority antidiabetic drugs due to their pronounce...